BC Cancer researchers leading the development of immunotherapies targeting the surface protein IL1RAP for the treatment of Ewing sarcoma

Dr. Poul Sorensen, Distinguished Scientist at BC Cancer, in collaboration with Dr. Kevin Hay, Clinician-Ccientist at BC Cancer, and Dr. Wei Li, Assistant Professor at the University of Pittsburgh, received support from the Rutledge Cancer Foundation to develop and optimize novel immunotherapies targeting the surface protein IL1RAP for the treatment of Ewing sarcoma.

Dr. Florian Kuchenbauer recognized with UBC outstanding academic performance for 2022

We are thrilled to announce that Dr. Florian Kuchenbauer, distinguished scientist of Terry Fox Laboratory (Kuchenbauer Lab) and associate professor at University of British Columbia, has been honored with the Outstanding Academic Performance (OAP) award from the UBC Faculty of Medicine in 2022.

Krystal Lab's new publication in Frontiers in Pharmacology

Congratulations to Dr. Hossein Rafiei, Michelle Yeung, Dr. Sara Kowalski, Dr. Gerald Krystal and Dr. Ingrid Elisia for their new publication titled, "Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis" in the Frontiers in Pharmacology journal, October 2023.

Back to top